Overview of Recent Developments at Verses AI Inc.

Verses AI Inc. (OTCQB: VRSSF), a Canadian cognitive‑computing company, has announced a series of corporate actions aimed at accelerating the commercialization of its agentic software systems. The company is focusing on the financial services sector, where it expects short‑term revenue growth, and has completed a significant restructuring of its workforce to reduce operating costs.

Strategic Re‑orientation and Cost Management

  • Management Action: Interim CEO David T. Scott and the board have implemented a strategic overhaul in response to market pressures.
  • Focus: The company is shifting its emphasis from research and development to the monetization of its agentic software platform, Genius™ (Geniustm), which is designed to deliver domain‑specific predictions and decisions under uncertainty.
  • Cost Reduction: A prior reduction in staff size was executed to lower operating expenses. The current strategy emphasizes a disciplined approach to market entry, concentrating resources on core initiatives to improve operational efficiency.

Corporate Update Webinar

  • Date & Time: 18 February 2026, 10 a.m. PST / 1 p.m. EST.
  • Speakers:
  • Interim CEO David T. Scott
  • President & COO James Hendrickson
  • CFO James Christodoulou
  • Purpose: The webinar will provide a comprehensive corporate overview and update on the company’s progress.
  • Registration: Investors can register at https://verses.wistia.com/live/events/wohm9p3wx3 .

Product Positioning

Verses AI’s flagship offering, Genius™, is a next‑generation agentic enterprise intelligence platform. It is built on first principles derived from science, physics, and biology, aiming to emulate the “wisdom and genius of Nature.” The platform is positioned to generate reliable predictions and decisions across various domains, with an immediate target market in financial services.

Market Context

  • Listing: OTC Bulletin Board.
  • Currency: USD.
  • Recent Share Price: $1.06 on 12 February 2026.
  • 52‑Week Range: $0.554 (25 January 2026) to $28.62 (2 March 2025).
  • Market Capitalization: $13,367,951.
  • Price‑to‑Earnings Ratio: –0.19, indicating negative earnings per share.

The company’s management emphasizes a focused, disciplined approach to bring its research outcomes to market, with the aim of achieving quick, revenue‑generating results in the financial services sector.